PubRank

J Sierra

Author PubWeight™ 127.26‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapse. Ann Oncol 2005 1.88
2 Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome. Bone Marrow Transplant 2006 1.67
3 Magnetic resonance imaging measurements and clinical changes accompanying transtentorial and foramen magnum brain herniation. Ann Neurol 1993 1.65
4 Lower respiratory tract respiratory virus infections increase the risk of invasive aspergillosis after a reduced-intensity allogeneic hematopoietic SCT. Bone Marrow Transplant 2009 1.45
5 Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Transplante Autólogo de Médula Osea Spanish Cooperative Group. J Clin Oncol 2001 1.43
6 The new Labcor-Santiago pericardial bioprosthesis. J Card Surg 1991 1.43
7 Predicting survival for myeloid leukemia after HLA-identical sibling donor allogeneic stem cell transplantation. Leukemia 2004 1.39
8 [Hematopoietic allogeneic transplantation with attenuated conditioning regimen on an outpatient basis. First experience in Spain]. Med Clin (Barc) 2001 1.39
9 Undetected viral infection in diffuse alveolar damage associated with bone marrow transplantation. Eur Respir J 1996 1.38
10 Hematopoietic stem cell transplantation in chronic lymphocytic leukemia: a report of 12 patients from a single institution. Ann Oncol 1998 1.37
11 Enhanced responses to Mycobacterium tuberculosis antigens by human alveolar lymphocytes during active pulmonary tuberculosis. J Infect Dis 1998 1.34
12 Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation. Bone Marrow Transplant 2002 1.31
13 Interleukin-3 receptor alpha chain (CD123) is widely expressed in hematologic malignancies. Haematologica 2001 1.30
14 Frequent severe liver iron overload after stem cell transplantation and its possible association with invasive aspergillosis. Bone Marrow Transplant 2004 1.29
15 Treatment of acute post-surgical infection of joint arthroplasty. Clin Microbiol Infect 2006 1.28
16 vnd, a gene required for early neurogenesis of Drosophila, encodes a homeodomain protein. EMBO J 1995 1.25
17 Second allogeneic bone marrow transplantation in acute leukemia: results of a survey by the European Cooperative Group for Blood and Marrow Transplantation. J Clin Oncol 2001 1.21
18 Reduced-intensity conditioning allogeneic transplantation is associated with a high incidence of extramedullary relapses in multiple myeloma patients. Leukemia 2006 1.20
19 Comparison of the classic Glucksberg criteria and the IBMTR Severity Index for grading acute graft-versus-host disease following HLA-identical sibling stem cell transplantation. International Bone Marrow Transplant Registry. Bone Marrow Transplant 1999 1.20
20 Acute myeloid leukemia with MLL rearrangements: clinicobiological features, prognostic impact and value of flow cytometry in the detection of residual leukemic cells. Leukemia 2003 1.17
21 Outcome and predictors of treatment failure in early post-surgical prosthetic joint infections due to Staphylococcus aureus treated with debridement. Clin Microbiol Infect 2011 1.14
22 Chimerism analysis following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning. Bone Marrow Transplant 2003 1.14
23 Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)]. Leukemia 2006 1.13
24 Autologous stem cell transplantation for clinically aggressive non-Hodgkin's lymphoma: the role of preparative regimens. Bone Marrow Transplant 2001 1.10
25 High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative Group. Ann Oncol 2003 1.08
26 Tuberculosis after hematopoietic stem cell transplantation: incidence, clinical characteristics and outcome. Spanish Group on Infectious Complications in Hematopoietic Transplantation. Bone Marrow Transplant 2000 1.06
27 Physical and psychosocial functioning of 117 survivors of bone marrow transplantation. Bone Marrow Transplant 1996 1.05
28 Comparable non-relapse mortality and survival after HLA-identical sibling blood stem cell transplantation with reduced or conventional-intensity preparative regimens for high-risk myelodysplasia or acute myeloid leukemia in first remission. Bone Marrow Transplant 2007 1.05
29 Elderly age and prior autologous transplantation have a deleterious effect on survival following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results from the Spanish multicenter prospective trial. Bone Marrow Transplant 2004 1.04
30 Growth rate of secondary hydatid cysts of the brain. Case report. J Neurosurg 1985 1.00
31 Expression of transforming growth factor-beta but not tumor necrosis factor-alpha, interferon-gamma, and interleukin-4 in granulomatous lung lesions in tuberculosis. Tuber Lung Dis 2000 1.00
32 Allogeneic transplantation of selected CD34+ cells from peripheral blood: experience of 62 cases using immunoadsorption or immunomagnetic technique. Spanish Group of Allo-PBT. Bone Marrow Transplant 1998 1.00
33 [Night blindness and xerophthalmia after surgery for morbid obesity]. Arch Soc Esp Oftalmol 2008 1.00
34 No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol 2000 0.99
35 Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results of a prospective multicentre study. Br J Haematol 2001 0.99
36 Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet 2000 0.97
37 Therapy of paraneoplastic pemphigus with Rituximab: a case report and review of literature. J Eur Acad Dermatol Venereol 2006 0.96
38 Pulmonary enterovirus infections in stem cell transplant recipients. Bone Marrow Transplant 1999 0.96
39 Activation of the NF-kappaB signalling pathway in diffuse large B-cell lymphoma: clinical implications. Histopathology 2008 0.95
40 Cytomegalovirus infection and disease after reduced intensity conditioning allogeneic stem cell transplantation: single-centre experience. Bone Marrow Transplant 2009 0.95
41 A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol 1996 0.94
42 MTX or mycophenolate mofetil with CsA as GVHD prophylaxis after reduced-intensity conditioning PBSCT from HLA-identical siblings. Bone Marrow Transplant 2010 0.93
43 Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation: comparison of recipients of positive CD34+ selected grafts with recipients of unmanipulated grafts. Exp Hematol 1999 0.93
44 Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Research. Bone Marrow Transplant 2007 0.92
45 Adverse impact of IDH1 and IDH2 mutations in primary AML: experience of the Spanish CETLAM group. Leuk Res 2012 0.92
46 Clinical utility of bone marrow flow cytometry in B-cell non-Hodgkin lymphomas (B-NHL). Histopathology 2004 0.91
47 Disparity for the minor histocompatibility antigen HA-1 is associated with an increased risk of acute graft-versus-host disease (GvHD) but it does not affect chronic GvHD incidence, disease-free survival or overall survival after allogeneic human leucocyte antigen-identical sibling donor transplantation. Br J Haematol 2001 0.91
48 Predictive value of Follicular Lymphoma International Prognostic Index (FLIPI) in patients with follicular lymphoma at first progression. Ann Oncol 2004 0.91
49 Neurologic complications of autologous and allogeneic bone marrow transplantation in patients with leukemia: a comparative study. Neurology 1996 0.90
50 Reduced-intensity conditioning reduces the risk of severe infections after allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 2001 0.89
51 Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies. Eur J Haematol 2005 0.89
52 Donor age and degree of HLA matching have a major impact on the outcome of unrelated donor haematopoietic cell transplantation for chronic myeloid leukaemia. Bone Marrow Transplant 2006 0.89
53 [Hypersensitivity vasculitis and granulomatous hepatitis induced by glybenclamide: a case report (author's transl)]. Med Clin (Barc) 1980 0.88
54 Bacteraemia caused by non-glucose-fermenting gram-negative bacilli and Aeromonas species in patients with haematological malignancies and solid tumours. Eur J Clin Microbiol Infect Dis 2000 0.88
55 Bacteremia caused by Capnocytophaga species in patients with neutropenia and cancer: results of a multicenter study. Clin Infect Dis 2001 0.87
56 Specific cutaneous involvement in Hodgkin's disease. Hematol Oncol 1992 0.87
57 Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin's lymphoma not achieving complete response after induction chemotherapy: the GEL/TAMO experience. Ann Oncol 2004 0.87
58 Bone marrow WT1 levels at diagnosis, post-induction and post-intensification in adult de novo AML. Leukemia 2013 0.86
59 Upper and lower respiratory tract infections by human enterovirus and rhinovirus in adult patients with hematological malignancies. Am J Hematol 2007 0.86
60 MEIS 1 expression is downregulated through promoter hypermethylation in AML1-ETO acute myeloid leukemias. Leukemia 2004 0.86
61 Interaction of CBF alpha/AML/PEBP2 alpha transcription factors with nucleosomes containing promoter sequences requires flexibility in the translational positioning of the histone octamer and exposure of the CBF alpha site. Biochemistry 2000 0.85
62 Cytomegalovirus pp65 antigenemia-guided pre-emptive treatment with ganciclovir after allogeneic stem transplantation: a single-center experience. Bone Marrow Transplant 1998 0.85
63 Intensive salvage chemotherapy for primary refractory or first relapsed adult acute lymphoblastic leukemia: results of a prospective trial. Haematologica 1999 0.85
64 Treatment of febrile neutropenia with cefepime monotherapy. Chemotherapy 2001 0.85
65 Pregnancy outcome in hematologic malignancies. Cancer 1991 0.85
66 Growth of vegetarian children: The Farm Study. Pediatrics 1989 0.85
67 CTLA-4 genotype and relapse incidence in patients with acute myeloid leukemia in first complete remission after induction chemotherapy. Leukemia 2008 0.85
68 Multiple myeloma with monoclonal IgG and IgD of lambda type exhibiting, under treatment, a shift from mainly IgG to mainly IgD. Immunology 1985 0.84
69 Meningitis caused by an unusual genotype (ST3) of Streptococcus suis. Infection 2012 0.84
70 Acute hepatomegaly with severe liver toxicity due to all-trans-retinoic acid. Haematologica 2000 0.84
71 Autologous stem cell transplantation for primary refractory Hodgkin's disease: results and clinical variables affecting outcome. Ann Oncol 2003 0.84
72 Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study. Spanish Group of Allo-PBT. Bone Marrow Transplant 1998 0.84
73 Low transplant-related mortality after second allogeneic peripheral blood stem cell transplant with reduced-intensity conditioning in adult patients who have failed a prior autologous transplant. Bone Marrow Transplant 2002 0.84
74 Rapid engraftment without significant graft-versus-host disease after allogeneic transplantation of CD34+ selected cells from peripheral blood. Blood 1997 0.84
75 Predictive factors for a successful mobilization of peripheral blood CD34+ cells in multiple myeloma. Ann Hematol 2001 0.84
76 On the reliability of clinical criteria for the diagnosis of hepatic veno-occlusive disease. Ann Hematol 1993 0.83
77 Prognostic indexes in follicular lymphoma: a comparison of different prognostic systems. Ann Oncol 2005 0.83
78 Allogeneic bone marrow transplantation for advanced Waldenstrom's macroglobulinemia. Bone Marrow Transplant 1999 0.83
79 Chronic systemic candidiasis in acute leukemia. Ann Hematol 1992 0.83
80 Intraventricular tuberculoma. Report of four cases in children. Neuroradiology 1987 0.82
81 Activation-associated phenotype of CD3 T cells in acute graft-versus-host disease. Clin Exp Immunol 2006 0.82
82 [Eyelid contact allergic eczema caused by topical ketorolac tromethamine 0.5%]. Arch Soc Esp Oftalmol 2006 0.82
83 The number of donor CD3(+) cells is the most important factor for graft failure after allogeneic transplantation of CD34(+) selected cells from peripheral blood from HLA-identical siblings. Blood 2001 0.82
84 Does reduced-intensity allogeneic transplantation confer a survival advantage to patients with poor prognosis chronic lymphocytic leukaemia? A case-control retrospective analysis. Ann Oncol 2009 0.82
85 Reduction of infection-related mortality after allogeneic PBSCT from HLA-identical siblings: longitudinal analysis from 1994 to 2008 at a single institution. Bone Marrow Transplant 2010 0.81
86 Immunophenotype of acute myeloid leukemia with NPM mutations: prognostic impact of the leukemic compartment size. Leuk Res 2010 0.81
87 Allogeneic or autologous stem cell transplantation following salvage chemotherapy for adults with refractory or relapsed acute lymphoblastic leukemia. Bone Marrow Transplant 1998 0.81
88 European survey of bone marrow transplantation in acute promyelocytic leukemia (M3). Working Party on Acute Leukemia of the European Cooperative Group for Bone Marrow Transplantation (EMBT). Bone Marrow Transplant 1994 0.81
89 Adverse prognostic impact of CD36 and CD2 expression in adult de novo acute myeloid leukemia patients. Leuk Res 2005 0.81
90 Hypocholesterolemia in acute myelogenous leukemia. Eur J Haematol 1988 0.81
91 Systemic mast cell disease associated with B-chronic lymphocytic leukemia. Haematologica 2001 0.81
92 Allogeneic transplantation of CD34+-selected cells from peripheral blood in patients with myeloid malignancies in early phase: a case control comparison with unmodified peripheral blood transplantation. Bone Marrow Transplant 2001 0.81
93 Typical CBFbeta/MYH11 fusion due to insertion of the 3'-MYH11 gene into 16q22 in acute monocytic leukemia with normal chromosomes 16 and trisomies 8 and 22. Cancer Genet Cytogenet 2000 0.81
94 Treatment of elderly patients with AML: results of an individualized approach. Haematologica 1998 0.80
95 Bacteremia by gram-negative bacilli in patients with hematologic malignancies. Comparison of the clinical presentation and outcome of infections by enterobacteria and non-glucose-fermenting gram-negative bacilli. Acta Haematol 1999 0.80
96 Endocarditis with pericardial bioprostheses: clinico-pathologic characteristics, immediate and long term prognosis. J Heart Valve Dis 1994 0.80
97 The effect of hormone replacement therapy on bone mass in patients with ovarian failure due to bone marrow transplantation. Maturitas 1996 0.79
98 Autologous stem cell transplantation for high-risk Hodgkin's disease: improvement over time and impact of conditioning regimen. Haematologica 2000 0.79
99 Dendritic and tumor cell fusions transduced with adenovirus encoding CD40L eradicate B-cell lymphoma and induce a Th17-type response. Gene Ther 2009 0.79
100 Transjugular liver biopsy in BMT. Bone Marrow Transplant 1993 0.79
101 Time sequential chemotherapy for primary refractory or relapsed adult acute myeloid leukemia: results of the phase II Gemia protocol. Haematologica 1999 0.79
102 Risk factors for early mortality in allogeneic bone marrow transplantation. A multivariate analysis on 174 leukaemia patients. Eur J Cancer 1993 0.79
103 [Fusarium solani bronchopneumonia in a patient with acute myeloblastic leukemia]. Enferm Infecc Microbiol Clin 1990 0.79
104 G-CSF increases the number of peripheral blood dendritic cells CD16+ and modifies the expression of the costimulatory molecule CD86+. Bone Marrow Transplant 2006 0.79
105 Allogeneic stem cell transplantation with reduced-intensity conditioning is potentially feasible as an outpatient procedure. Bone Marrow Transplant 2003 0.79
106 Interstitial pneumonitis after BMT: 15 years experience in a single institution. Bone Marrow Transplant 1993 0.79
107 Absence of veno-occlussive disease in a cohort of multiple myeloma patients undergoing autologous stem cell transplantation with targeted busulfan dosage. Eur J Haematol 2006 0.79
108 Continuous haemodynamic monitoring using transoesophageal Doppler during acute normovolaemic haemodilution in patients with coronary artery disease. Anaesthesia 2004 0.79
109 Allogeneic peripheral blood stem cell transplantation with CD34+-cell selection and delayed T-cell add-back in adults. Results of a single center pilot study. Haematologica 2000 0.78
110 Mini-ICE regimen as mobilization therapy for chronic myelogenous leukaemia patients at diagnosis. Bone Marrow Transplant 1999 0.78
111 Reduced-intensity conditioning allogeneic hematopoietic cell transplantation using oral fludarabine as part of the conditioning regimen. Cytotherapy 2009 0.78
112 Feasibility and recent improvement of autologous stem cell transplantation for acute myelocytic leukaemia in patients over 60 years of age: importance of the source of stem cells. Br J Haematol 2000 0.78
113 Bronchoscopy guided by high-resolution computed tomography for the diagnosis of pulmonary infections in patients with hematologic malignancies and normal plain chest X-ray. Haematologica 2000 0.78
114 Cardiovascular response to acute normovolaemic haemodilution in patients with severe aortic stenosis: assessment with transoesophageal echocardiography. Anaesthesia 2004 0.78
115 Exuberant granulation tissue associated with chronic graft-versus-host disease after transplantation of peripheral blood progenitor cells. J Am Acad Dermatol 1999 0.78
116 Measurement of liver iron overload by magnetic induction using a planar gradiometer: preliminary human results. Physiol Meas 2004 0.78
117 Instability of the CGG repeat at the FRAXA locus and variable phenotypic expression in a large fragile X pedigree. J Med Genet 1995 0.77
118 Leukemic relapse as T-acute lymphoblastic leukemia in a patient with acute myeloid leukemia and a minor T-cell clone at diagnosis. Haematologica 2000 0.77
119 Community respiratory virus infections in patients with hematologic malignancies. Haematologica 1999 0.77
120 Allogeneic transplantation of purified CD34+ cells from peripheral blood: Spanish experience of 62 cases. Spanish Group of allo-PBT. Bone Marrow Transplant 1998 0.77
121 Clinical efficacy and safety of Flebogammadif, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpura. Transfus Med 2009 0.76
122 Thromboembolism in patients with pericardial valves in the absence of chronic anticoagulation: 12 years' experience. Eur J Cardiothorac Surg 1991 0.76
123 Mouth-washings with recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) do not improve grade III-IV oropharyngeal mucositis (OM) in patients with hematological malignancies undergoing stem cell transplantation. Results of a randomized double-blind placebo-controlled study. Bone Marrow Transplant 2002 0.76
124 Is partially reversible pulmonary hypertension a contraindication for heart transplantation? Transplant Proc 2000 0.76
125 Incidence, characteristics and risk factors of marked hyperbilirubinemia after allogeneic hematopoietic cell transplantation with reduced-intensity conditioning. Bone Marrow Transplant 2012 0.76
126 Effect of large doses of methylprednisolone on supratentorial intracranial tumors. A clinical and CAT scan evaluation. Eur Neurol 1985 0.76
127 CD66 expression in acute leukaemia. Ann Hematol 2000 0.76
128 Flow cytometry using the monoclonal antibody CD10-Pe/Cy5 is a useful tool to identify follicular lymphoma cells. Eur J Haematol 2001 0.76
129 Isolation of CD34+ progenitor cells from peripheral blood by use of an automated immunomagnetic selection system: factors affecting the results. Transfusion 2000 0.76
130 Sequence conservation of RAG-1 and RAG-2 genes in hematologic malignancies. Leukemia 2002 0.76
131 Severe infections after single umbilical cord blood transplantation in adults with or without the co-infusion of CD34+ cells from a third-party donor: results of a multicenter study from the Grupo Español de Trasplante Hematopoyético (GETH). Transpl Infect Dis 2015 0.76
132 Novel approach to mitral valve repair in childhood dilated cardiomyopathy. Minerva Chir 2011 0.76
133 Effects of G-CSF administration and peripheral blood progenitor cell collection in 20 healthy donors. Ann Hematol 1996 0.76
134 Low-grade lymphoma: clinical and prognostic studies in a series of 143 patients from a single institution. Leuk Lymphoma 1994 0.75
135 Autologous stem cell transplantation for poor prognosis Hodgkin's disease in first complete remission: a retrospective study from the Spanish GEL-TAMO cooperative group. Bone Marrow Transplant 1997 0.75
136 Intensified prophylaxis of febrile neutropenia with ofloxacin plus rifampin during severe short-duration neutropenia in patients with lymphoma. Leuk Lymphoma 1999 0.75
137 Autologous bone marrow transplantation for non-Hodgkin's lymphoma in first remission. Blood 1993 0.75
138 Insertion of the CCND1 gene into the IgH locus in a case of leukaemic small cell mantle lymphoma with normal chromosomes 11 and 14. J Clin Pathol 2003 0.75
139 Merkel cell carcinoma developing after bone marrow transplantation. Dermatology 2000 0.75
140 Splenic abscess due to Fusobacterium necrophorum. Rev Infect Dis 1992 0.75
141 Whether methotrexate administration in graft-versus-host disease prophylaxis significantly delays the engraftment in allogeneic peripheral blood progenitor cell transplantation. Blood 1995 0.75
142 CDC group IV c-2 bacteremia in stem cell transplant recipients. Bone Marrow Transplant 1998 0.75
143 Flow cytometric detection of B cell abnormal maturation in chronic myeloid leukemia. Leukemia 2000 0.75
144 [Essential thrombocythemia developing into acute leukemia]. Med Clin (Barc) 1983 0.75
145 Spectrophotometric and chromatographic determination of omeprazole in pharmaceutical formulations. Pharm Dev Technol 2009 0.75
146 Autologous bone marrow transplantation for acute lymphoblastic leukemia: role of bone marrow purging. Prog Clin Biol Res 1994 0.75
147 [Prognosis in acute non-lymphoblastic leukemia]. Med Clin (Barc) 1987 0.75
148 Echocardiographic features of the normofunctional Labcor-Santiago pericardial bioprosthesis. J Heart Valve Dis 1994 0.75
149 TEL rearrangements in acute lymphoblastic leukemia: association with p16 deletions in relapsed cases. Haematologica 2001 0.75
150 Successful autografting in chronic myelogenous leukaemia using Philadelphia negative blood progenitor cells mobilized with rHuG-CSF alone in a patient responding to alpha-interferon. Br J Haematol 1997 0.75
151 Familial spastic paraplegia with neuropathy and poikiloderma. A new syndrome? Clin Genet 1992 0.75
152 [Severe accidental hypothermia: rewarming by total cardiopulmonary bypass]. Rev Esp Anestesiol Reanim 1994 0.75
153 T-cell lymphoblastic lymphoma associated with the t(6;11)(q27;q23). Haematologica 2001 0.75
154 [Reproducibility of the FAB classification and prognostic value of the principle cytologic characteristics in 147 cases of acute non-lymphoblastic leukemia]. Sangre (Barc) 1986 0.75
155 Unsaturated fatty acids and human mononuclear cell function. Prog Lipid Res 1981 0.75
156 The effects of diazepam on self-informed arousal and sustained attention. Eur Psychiatry 1996 0.75
157 [IgA nephropathy in childhood]. An Esp Pediatr 1987 0.75
158 [Allogenic transplant of non-manipulated hematopoietic progenitor peripheral blood cells. Spanish experience of 79 cases. Allo-Peripheral Blood Transplantation Group]. Sangre (Barc) 1997 0.75
159 [Hemopoietic progenitor cell transplantation: 20 years' experience at the Hematology School "Farreras-Valentí"/Clinical Hospital of Barcelona]. Med Clin (Barc) 1997 0.75
160 [Marin-Amat and inverted Marcus-Gunn syndrome. Two case reports]. An Pediatr (Barc) 2011 0.75
161 High-dose ifosfamide and etoposide infusion plus methylprednisolone for refractory or relapsed aggressive non-Hodgkin's lymphoma. Haematologica 2000 0.75
162 Hematological recovery after autologous bone marrow transplantation in acute leukemia: predictive factors. J Hematother 1993 0.75
163 The value of detecting surface and cytoplasmic antigens in acute myeloid leukaemia. Br J Haematol 1992 0.75
164 [Minimal invasive cardiac surgery]. Rev Med Suisse 2015 0.75
165 Large-cell lymphoma: a study of prognostic factors and assessment of five recently proposed predictive systems. Leuk Lymphoma 1993 0.75
166 Safety and efficacy of low-dose amphotericin B lipid complex for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies. Methods Find Exp Clin Pharmacol 2001 0.75
167 [Anti-nuclear envelope antibodies associated with Sjogren's syndrome and non-Hodgkin's lymphoma]. Med Clin (Barc) 1990 0.75
168 [Fatal paraquat poisoning. Presentation of 2 new cases and review of the literature]. Med Clin (Barc) 1983 0.75
169 Androgen-binding proteins from human hyperplastic prostate as evaluated by electrophoresis. Arch Androl 1986 0.75
170 [Acute lymphoblastic leukemia: use of the F.A.B. group score and analysis of the prognostic value of the bone marrow morphology examination in 92 patients]. Sangre (Barc) 1986 0.75
171 [Acute lymphoblastic leukemia in adults: results of the DATOP-79 protocol]. Med Clin (Barc) 1988 0.75
172 Hypertriglyceridemia in bone marrow transplant recipients: another side effect of cyclosporine A. Bone Marrow Transplant 1989 0.75
173 Salvage chemotherapy with IAPVP-16 for advanced refractory or relapsed follicular lymphomas. Haematologica 1999 0.75
174 [Treatment of resistant or relapsing non-Hodgkin lymphomas]. Med Clin (Barc) 1989 0.75
175 [Endocarditis with Ionescu-Shiley's bioprosthesis. Long-term results]. Rev Esp Cardiol 1989 0.75
176 Cardiac sarcoma originating from the tricuspid valve. J Card Surg 2001 0.75
177 [Bone marrow autotransplant: preliminary results in 20 patients with acute leukemia]. Med Clin (Barc) 1989 0.75
178 CD56 expression could be associated with monocytic differentiation in acute myeloid leukemia with t(8;21). Haematologica 2001 0.75
179 [Natural history of non-Hodgkin's lymphoma with a "favorable" histology in an advanced stage]. Sangre (Barc) 1987 0.75
180 Autologous or allogeneic stem cell transplantation in advanced low-grade lymphomas? Blood 1998 0.75
181 [Association of bone marrow aplasia and pregnancy: new cases]. Med Clin (Barc) 1985 0.75
182 Amphotericin B lipid complex at 3 mg/kg/day for treatment of invasive fungal infections in adults with haematological malignancies. J Antimicrob Chemother 1999 0.75
183 [Endocardial cushion defect without ostium primum atrial septal defect associated with tetralogy of Fallot (author's transl)]. An Esp Pediatr 1982 0.75
184 [Choroidal metastasis as first manifestation of tumor relapse]. Arch Soc Esp Oftalmol 2000 0.75
185 Doppler echocardiographic evaluation of the Bioflo pericardial bioprosthesis. J Heart Valve Dis 1993 0.75
186 [Intraocular lenses with blue light filter]. Arch Soc Esp Oftalmol 2005 0.75
187 Prognostic factors influencing feasibility of cytogenetic and molecular analysis in leukapheresis products in chronic myelogenous leukemia patients. Ann Hematol 2002 0.75
188 [Granulocytic sarcoma in the cervix uteri as form of relapse of an acute myeloblastic leukemia]. Sangre (Barc) 1985 0.75
189 Marrow transplants from unrelated donors. Clin Transpl 1995 0.75
190 Acute megaloblastic anemia: homocysteine levels are useful for diagnosis and follow-up. Haematologica 1999 0.75
191 [Gastric lymphoma followed by gastric adenocarcinoma with collision of the tumors]. Rev Esp Enferm Apar Dig 1988 0.75
192 Predicting survival for myeloid leukemia after HLA-identical sibling donor allogeneic stem cell transplantation. Leukemia 2004 0.75
193 AML-1 mutations outside the RUNT domain: description of two cases in myeloid malignancies. Leukemia 2002 0.75
194 Regulation of the blood glucose concentration in normal rabbits. Acta Physiol Lat Am 1967 0.75
195 Haematology. The periphery is now central. Lancet 1998 0.75
196 Patients with biochemical iron overload: causes and characteristics of a cohort of 150 cases. Ann Hematol 2003 0.75
197 [Allogeneic transplant of peripheral blood hematopoietic progenitors. Preliminary experience]. Med Clin (Barc) 1996 0.75
198 Loss of heterozygosity of the polymorphic PIG3 microsatellite with low frequency in de novo acute myeloid leukemias. Leukemia 2004 0.75
199 [Gastric adenocarcinoma associated with Hodgkin's disease with infiltration of the tonsils and gastric serous membrane]. Med Clin (Barc) 1984 0.75
200 [Allogenic bone marrow transplantation in multiple myeloma. Analysis of 12 consecutive cases]. Med Clin (Barc) 1995 0.75
201 Ultrastructural variations of the rat fetal adrenal cortex after maternal bilateral adrenalectomy and exogen glucocorticoid administration. Acta Biol Hung 1995 0.75
202 Prognostic factors in patients who received autologous bone marrow transplantation for non-Hodgkin's lymphoma. Report of 104 patients from the Spanish Cooperative Group GEL/TAMO. Bone Marrow Transplant 1994 0.75
203 [Intravenous amphotericin B as prevention of deep mycoses in allogeneic bone marrow transplantation]. Med Clin (Barc) 1994 0.75
204 An unusual case of Castleman's disease restricted to the neck. ORL J Otorhinolaryngol Relat Spec 1992 0.75
205 [Contribution of PET-CT imaging to head and neck oncology]. Acta Otorrinolaringol Esp 2005 0.75
206 [Surgical correction of interauricular communication in adults]. Rev Quir Esp 1990 0.75
207 [Neurocutaneous disorders with large dyschromia: incontinentia pigmenti, achromic nevus]. Rev Neurol 1996 0.75
208 [Valves of the posterior urethra: case reviews]. An Esp Pediatr 1986 0.75
209 Bone marrow purging in acute lymphoblastic leukemia: biological and clinical features. J Hematother 1994 0.75
210 Autologous bone marrow transplantation in 22 adult patients with lymphoblastic lymphoma responsive to conventional dose chemotherapy. Bone Marrow Transplant 1992 0.75
211 [Clinical significance of dissociated cholestasis as a biological syndrome (author's transl)]. Med Clin (Barc) 1981 0.75
212 Papillary fibroelastoma as a cause of cardioembolic stroke. Heart 2002 0.75
213 [Adult acute lymphoblastic leukemia: preliminary results of the LAL-86 protocol]. Sangre (Barc) 1990 0.75
214 [VM-26 and cytosine arabinoside in the treatment of acute refractory lymphoblastic leukemia in adults]. Sangre (Barc) 1984 0.75
215 Demonstration of donor origin of CD34+ HLA-DR- bone marrow cells after allogeneic peripheral blood transplantation with a long follow-up. Bone Marrow Transplant 1998 0.75
216 [Effects of low doses of aprotinin in heart surgery]. Rev Esp Anestesiol Reanim 1994 0.75
217 Thrombocytopenia due to use of teicoplanin. Clin Infect Dis 1993 0.75
218 [Acral erythema induced by cytostatic polychemotherapy]. Med Clin (Barc) 1987 0.75
219 Interleukin-2 after T-cell-depleted allogeneic bone marrow transplantation. Blood 1995 0.75
220 GM-CSF administration enhances granulocytic recovery in purged autologous bone marrow transplantation for acute lymphoblastic leukemia. Prog Clin Biol Res 1992 0.75
221 [Cholesterol granuloma of the temporal lobe]. Acta Otorrinolaringol Esp 1996 0.75
222 [Intensive polychemotherapy in the treatment of acute non-lymphoblastic leukemia: comparison of the prospective protocols DATOP/79 and DATOP/82]. Med Clin (Barc) 1987 0.75
223 Study of hematopoietic chimerism following allogeneic peripheral blood stem cell transplantation using PCR amplification of short tandem repeats. Ann Hematol 1996 0.75
224 [Waldenström's macroglobulinemia and arthritis]. Med Clin (Barc) 1990 0.75
225 Low-dose amphotericin B lipid complex for the treatment of persistent fever of unknown origin in patients with hematologic malignancies and prolonged neutropenia. Chemotherapy 1999 0.75
226 [Tendinitis due to fluoroquinolones. Description of 2 cases]. Med Clin (Barc) 1994 0.75
227 [Mutational analysis of p53 in T-cell lymphoblastic leukemia]. Med Clin (Barc) 2000 0.75
228 Unrelated and HLA-nonidentical related donor marrow transplantation for thalassemia and leukemia. A combined report from the Seattle Marrow Transplant Team and the International Bone Marrow Transplant Registry. Ann N Y Acad Sci 1998 0.75
229 MLL tandem duplication in two cases of acute myelocytic leukemia with unbalanced translocations: der(16)t(11;16)(q23;p13) and der(18)t(11;18)(q22;p11.2). Cancer Genet Cytogenet 2003 0.75
230 [Allogeneic transplant of CD34+ peripheral blood cells from HLA-identical donors: Spanish experience of 40 cases. Allo-Peripheral Blood Transplantation Group]. Sangre (Barc) 1997 0.75
231 [Hepatic coma secondary to hepatic metastases of a lung cancer]. Med Clin (Barc) 1982 0.75
232 Autologous stem cell transplantation in advanced follicular lymphoma. A single center experience. Haematologica 1999 0.75
233 [Immunophenotyping study of bone marrow fractions obtained by elutriation in allogeneic bone marrow transplantation]. Sangre (Barc) 1993 0.75
234 [Molecular genetic study in congenital myotonic dystrophy]. Rev Neurol 1997 0.75
235 Allogenic transplants with peripheral blood progenitor cells: a report of six cases. Leuk Lymphoma 1996 0.75
236 [Diagnosis and intensive treatment of acute leukemia in pregnancy]. Med Clin (Barc) 1987 0.75
237 Immunophenotypic characteristics of blast crisis of chronic myeloid leukaemia: correlations with clinico-biological features and survival. Leukemia 1993 0.75
238 [Osteolytic lesions in idiopathic myelofibrosis: presentation of 2 cases]. Med Clin (Barc) 1983 0.75
239 Characteristics of red cell pyruvate kinase (PK) and pyrimidine 5'nucleotidase (P5N) abnormalities in acute leukaemia and chronic lymphoid diseases with leukaemic expression. Br J Haematol 1987 0.75
240 [Transfusion related graft versus host disease. Indications for irradiated blood components]. Sangre (Barc) 1999 0.75
241 Inappropriate secretion of antidiuretic hormone as the initial sign of central nervous system progression of nocardiosis in a patient with chronic lymphocytic leukemia. Haematologica 1999 0.75
242 [Essential thromboembolism: study of 9 cases]. Med Clin (Barc) 1985 0.75
243 [Second allogeneic progenitor cell transplantation for leukemia relapse: results in 10 patients]. Med Clin (Barc) 1997 0.75
244 [Lennert's lymphoma. Clinicopathological study of one case (author's transl)]. Sangre (Barc) 1981 0.75
245 Allogeneic hematopoietic stem cell transplantation after immunosuppressive but non-myeloablative conditioning: "miniallografts" are no small matter. Haematologica 1998 0.75
246 Unrelated donor bone marrow transplantation as treatment for chronic myeloid leukemia: the Spanish experience. The Chronic Myeloid Leukemia Subcommittee of the GETH. Grupo Español de Trasplante Hemopoyético. Haematologica 2000 0.75
247 Combined use of reverse transcriptase polymerase chain reaction and flow cytometry to study minimal residual disease in Philadelphia positive acute lymphoblastic leukemia. Haematologica 2000 0.75
248 Mini-ICE regimen allows mobilization of peripheral blood progenitor cells in a patient with chronic myelogenous leukemia failing the ICE protocol. Haematologica 2000 0.75
249 [Idiopathic thrombocytopenic purpura and delivery]. Med Clin (Barc) 1988 0.75
250 [The prognostic factors of early mortality in bone marrow transplantation in patients with chronic myeloid leukemia]. Rev Clin Esp 1994 0.75
251 Favourable effect of the combination of acute and chronic graft-versus-host disease on the outcome of allogeneic peripheral blood stem cell transplantation for advanced haematological malignancies. Br J Haematol 2001 0.75
252 [Simple refractory anemia. Response to treatment using maturative factors]. Med Clin (Barc) 1989 0.75
253 Mobilization kinetics of peripheral blood progenitor cells after IAPVP-16 salvage chemotherapy plus G-CSF in lymphoproliferative disorders. Bone Marrow Transplant 2000 0.75